These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16343870)

  • 1. [Pharmacovigilance of vaccines].
    Autret-Leca E; Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F
    Arch Pediatr; 2006 Feb; 13(2):175-80. PubMed ID: 16343870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vaccines pharmacovigilance].
    Autret-Leca E; Jonville-Béra AP; Beau-Salinas F
    Rev Prat; 2004 Mar; 54(5):526-31. PubMed ID: 15176512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacovigilance in veterinary medicine in Chile: a pilot study.
    Iragüen D; Urcelay S; San Martín B
    J Vet Pharmacol Ther; 2011 Apr; 34(2):108-15. PubMed ID: 21395600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Active drug monitoring of adverse drug reactions in pediatric emergency department].
    Planchamp F; Nguyen KA; Vial T; Nasri S; Javouhey E; Gillet Y; Ranchin B; Villard F; Floret D; Cochat P; Gueyffier F; Kassaï B;
    Arch Pediatr; 2009 Feb; 16(2):106-11. PubMed ID: 19117738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post licensure safety surveillance for Prevenar].
    Bensouda-Grimaldi L; Jonville-Béra AP; Autret-Leca E
    Arch Pediatr; 2007 Jul; 14(7):870-4. PubMed ID: 17442548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Organization and results of drug vigilance in France].
    Bégaud B; Chaslerie A; Haramburu F
    Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veterinary pharmacovigilance in the European context.
    Keck G
    Ann Ist Super Sanita; 1992; 28(4):425-8. PubMed ID: 1303032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine.
    Zent O; Hennig R
    Vaccine; 2004 Dec; 23(5):579-84. PubMed ID: 15542177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants].
    Castot A; Djezzar S; Deleau N; Guillot B; Efthymiou ML
    Therapie; 1997; 52(2):97-103. PubMed ID: 9231502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New methods for studying drug associated risk: experience of the Toulouse Regional Pharmacovigilance Center].
    Montastruc JL; Bagheri H; Lacroix I; Olivier P; Durrieu G; Damase-Michel C; Lapeyre-Mestre M
    Bull Acad Natl Med; 2005 Mar; 189(3):493-502; discussion 502-5. PubMed ID: 16149213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions in children in Camagüey Province, Cuba.
    Arencibia ZB; Sotomayor DN; Mollinedo NC; Choonara I; Manzano EF; Leyva AL
    Arch Dis Child; 2010 Jun; 95(6):474-7. PubMed ID: 20501541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions: a review of relevant factors.
    Ajayi FO; Sun H; Perry J
    J Clin Pharmacol; 2000 Oct; 40(10):1093-101. PubMed ID: 11028248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.